Dr. Michael D. Mix
Claim this profileState University of New York Upstate Medical University
Studies Lung Cancer
Studies Cancer
10 reported clinical trials
27 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage I
Stage II
2Cancer
Stage IV
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Michael D. Mix is currently running
Stereotactic Radiosurgery vs. HA-WBRT + Memantine
for Brain Cancer
Stereotactic radiosurgery (SRS) is a commonly used treatment for brain tumors. It is a one-day (or in some cases two day), out-patient procedure during which a high dose of radiation is delivered to small spots in the brain while excluding the surrounding normal brain. Whole brain radiation therapy with hippocampal avoidance (HA-WBRT) is when radiation therapy is given to the whole brain, while trying to decrease the amount of radiation that is delivered to the area of the hippocampus. The hippocampus is a brain structure that is important for memory. Memantine is a drug that is given to help relieve symptoms that can be caused by WBRT, including problems with memory and other mental symptoms. Health Canada, the regulatory body that oversees the use of drugs in Canada, has not approved the sale or use of memantine in combination with WBRT to treat this kind of cancer, although they have allowed its use in this study.
Recruiting2 awards Phase 3
Stereotactic Radiosurgery vs Whole-Brain Radiotherapy
for Brain Metastasis from Lung Cancer
This phase III trial compares the effect of stereotactic radiosurgery to standard of care memantine and whole brain radiation therapy that avoids the hippocampus (the memory zone of the brain) for the treatment of small cell lung cancer that has spread to the brain. Stereotactic radiosurgery is a specialized radiation therapy that delivers a single, high dose of radiation directly to the tumor and may cause less damage to normal tissue. Whole brain radiation therapy delivers a low dose of radiation to the entire brain including the normal brain tissue. Hippocampal avoidance during whole-brain radiation therapy (HA-WBRT) decreases the amount of radiation that is delivered to the hippocampus which is a brain structure that is important for memory. The drug, memantine, is also often given with whole brain radiotherapy because it may decrease the risk of side effects related to thinking and memory. Stereotactic radiosurgery may decrease side effects related to memory and thinking compared to standard of care HA-WBRT plus memantine.
Recruiting2 awards Phase 315 criteria
More about Michael D. Mix
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Michael D. Mix has experience with
- Carboplatin
- Paclitaxel
- Atezolizumab
- Stereotactic Body Radiation Therapy
- HFR Radiation Therapy
- Docetaxel
Breakdown of trials Michael D. Mix has run
Lung Cancer
Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Michael D. Mix specialize in?
Michael D. Mix focuses on Lung Cancer and Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage I.
Is Michael D. Mix currently recruiting for clinical trials?
Yes, Michael D. Mix is currently recruiting for 6 clinical trials in Syracuse New York. If you're interested in participating, you should apply.
Are there any treatments that Michael D. Mix has studied deeply?
Yes, Michael D. Mix has studied treatments such as Carboplatin, Paclitaxel, Atezolizumab.
What is the best way to schedule an appointment with Michael D. Mix?
Apply for one of the trials that Michael D. Mix is conducting.
What is the office address of Michael D. Mix?
The office of Michael D. Mix is located at: State University of New York Upstate Medical University, Syracuse, New York 13210 United States. This is the address for their practice at the State University of New York Upstate Medical University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.